Literature DB >> 29532097

[Once-a-week versus once-every-three-weeks cisplatin application in combined chemoradiotherapy for locally advanced head and neck cancer?]

Martina Becker-Schiebe1, Hans Christiansen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29532097     DOI： 10.1007/s00066-018-1283-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  11 in total

1.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

Authors:  Jacques Bernier; Christian Domenge; Mahmut Ozsahin; Katarzyna Matuszewska; Jean-Louis Lefèbvre; Richard H Greiner; Jordi Giralt; Philippe Maingon; Frédéric Rolland; Michel Bolla; Francesco Cognetti; Jean Bourhis; Anne Kirkpatrick; Martine van Glabbeke
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

2.  The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck.

Authors:  Kazim Uygun; Ahmet Bilici; Hakan Karagol; Murat Caloglu; Irfan Cicin; Gorkem Aksu; Merdan Fayda; Sernaz Uzunoglu
Journal:  Cancer Chemother Pharmacol       Date:  2009-01-03       Impact factor: 3.333

Review 3.  Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review.

Authors:  Primož Strojan; Jan B Vermorken; Jonathan J Beitler; Nabil F Saba; Missak Haigentz; Paolo Bossi; Francis P Worden; Johannes A Langendijk; Avraham Eisbruch; William M Mendenhall; Anne W M Lee; Louis B Harrison; Carol R Bradford; Robert Smee; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-07-14       Impact factor: 3.147

4.  Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial.

Authors:  Sarbani Ghosh-Laskar; Nikhil Kalyani; Tejpal Gupta; Ashwini Budrukkar; Vedang Murthy; Manju Sengar; Devendra Chaukar; Prathamesh Pai; Pankaj Chaturvedi; Anil D'Cruz; Jaiprakash Agarwal
Journal:  Head Neck       Date:  2015-05-22       Impact factor: 3.147

5.  A Comparative Study on Weekly Versus Three Weekly Cisplatinum Based Chemoradiation in Locally Advanced Head and Neck Cancers.

Authors:  Tapan Kumar Sahoo; Dipti Rani Samanta; Surendra Nath Senapati; Karishma Parida
Journal:  J Clin Diagn Res       Date:  2017-01-01

6.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Authors:  Jean-Pierre Pignon; Aurélie le Maître; Emilie Maillard; Jean Bourhis
Journal:  Radiother Oncol       Date:  2009-05-14       Impact factor: 6.280

Review 7.  Cisplatin in cancer therapy: molecular mechanisms of action.

Authors:  Shaloam Dasari; Paul Bernard Tchounwou
Journal:  Eur J Pharmacol       Date:  2014-07-21       Impact factor: 4.432

8.  An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

Authors:  David J Adelstein; Yi Li; George L Adams; Henry Wagner; Julie A Kish; John F Ensley; David E Schuller; Arlene A Forastiere
Journal:  J Clin Oncol       Date:  2003-01-01       Impact factor: 44.544

9.  A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.

Authors:  W Budach; T Hehr; V Budach; C Belka; K Dietz
Journal:  BMC Cancer       Date:  2006-01-31       Impact factor: 4.430

10.  The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity.

Authors:  Din-Li Tsan; Chien-Yu Lin; Chung-Jan Kang; Shiang-Fu Huang; Kang-Hsing Fan; Chun-Ta Liao; I-How Chen; Li-Yu Lee; Hung-Ming Wang; Joseph Tung-Chieh Chang
Journal:  Radiat Oncol       Date:  2012-12-18       Impact factor: 3.481
View more
  2 in total

Review 1.  Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer-a meta-analysis.

Authors:  Jan Haussmann; Bálint Tamaskovics; Edwin Bölke; Freddy-Joel Djiepmo-Njanang; Kai Kammers; Stefanie Corradini; Matthias Hautmann; Pirus Ghadjar; Kitti Maas; Patrick J Schuler; Thomas K Hoffmann; Guido Lammering; Wilfried Budach; Christiane Matuschek
Journal:  Strahlenther Onkol       Date:  2019-10-04       Impact factor: 3.621

2.  Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.

Authors:  Xiaozhong Liao; Ying Gao; Jiahui Liu; Lanting Tao; Jun Xie; Yueyu Gu; Taoli Liu; Dongmei Wang; Dan Xie; Suilin Mo
Journal:  Front Oncol       Date:  2020-09-10       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.